Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

1.43
BATS BZX Real-Time Price
As of 10:54am ET
 +0.03 / +2.14%
Today’s Change
1.18
Today|||52-Week Range
4.74
-42.34%
Year-to-Date
No recent news for Solazyme Inc.

Today’s Trading

Previous close1.40
Today’s open1.43
Day’s range1.38 - 1.48
Volume71,070
Average volume (3 months)514,727
Market cap$112.3M
Dividend yield--
Data as of 10:54am ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-18.23%
Earnings growth (this year)+16.20%
Earnings growth (next 5 years)+683.60%
Revenue growth (last year)+51.93%
P/E ratioNM
Price/Sales3.24
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...+0.05+1.67%
PIPPharmAthene Inc-0.01-0.58%
CYTRCytRx Corp+0.06+3.44%
BPTHBio Path Holdings In...+0.04+2.99%
Data as of 10:39am ET, 02/10/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$60.4M
Annual profit (last year)-$162.1M
Net profit margin-268.49%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
Chief Executive Officer &
Director
Jonathan S. Wolfson
Chief Operating &
Financial Officer
Tyler W. Painter
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers